- Rank in Search Criteria: 11621
World Rank (Jan-05-2024): 18,547
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 19187
Market Cap (Jul-30-2023): 0.16 Billion USD
World Rank (Jan-2022): 21,101
Market Cap (Jan-2022): 0.14 Billion USD
- Rank in Search Criteria: 11622
World Rank (Jan-05-2024): 18,548
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 17107
Market Cap (Jul-30-2023): 0.24 Billion USD
World Rank (Jan-2022): 4,633
Market Cap (Jan-2022): 3.18 Billion USDHeadquarters Country: China Annual Revenue in USD: 13 Million USD
Annual Net Income in USD: -339 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 228
Employee Count as of Date: As on 2020
Company Profile: I-Mab is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company annual revenue is 114.5 million USD. The headquarters is in China.
- Rank in Search Criteria: 11623
World Rank (Jan-05-2024): 18,550
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 19141
Market Cap (Jul-30-2023): 0.16 Billion USD
World Rank (Jan-2022): 18,218
Market Cap (Jan-2022): 0.23 Billion USD
- Rank in Search Criteria: 11624
World Rank (Jan-05-2024): 18,553
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 18727
Market Cap (Jul-30-2023): 0.18 Billion USD
World Rank (Jan-2022): 19,991
Market Cap (Jan-2022): 0.17 Billion USDHeadquarters Country: Japan
- Rank in Search Criteria: 11625
World Rank (Jan-05-2024): 18,554
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 18742
Market Cap (Jul-30-2023): 0.18 Billion USD
World Rank (Jan-2022): 18,779
Market Cap (Jan-2022): 0.21 Billion USDHeadquarters Country: Japan
- Rank in Search Criteria: 11626
World Rank (Jan-05-2024): 18,555
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 19908
Market Cap (Jul-30-2023): 0.14 Billion USD
- Rank in Search Criteria: 11627
World Rank (Jan-05-2024): 18,558
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 20767
Market Cap (Jul-30-2023): 0.12 Billion USD
World Rank (Jan-2022): 18,633
Market Cap (Jan-2022): 0.22 Billion USD
- Rank in Search Criteria: 11628
World Rank (Jan-05-2024): 18,560
World Rank (Jul-30-2023): 18560
World Rank (Jan-2022): 18,560
Headquarters Country: Japan
- Rank in Search Criteria: 11629
World Rank (Jan-05-2024): 18,561
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 19864
Market Cap (Jul-30-2023): 0.14 Billion USD
- Rank in Search Criteria: 11630
World Rank (Jan-05-2024): 18,562
Market Cap (Jan-05-2024): 0.18 Billion USD
World Rank (Jul-30-2023): 19971
Market Cap (Jul-30-2023): 0.14 Billion USD
World Rank (Jan-2022): 21,918
Market Cap (Jan-2022): 0.12 Billion USDHeadquarters Country: Japan